Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

FDA recall notice · announced March 15, 2017 · Mylan Institutional, Inc. (d.b.a. Udl Laboratories)

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Reason for recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Notes

Distribution: Nationwide
Lot/code information: Batch #3083289; Exp. Date 12/2018
Quantity: 58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
Status: Terminated
Products in this recall event:
- Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20 (D-0493-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.